Research & Development



  雲瑯皺眉道︰“大閼氏?”   早在雲瑯離開上林苑的時候,司馬遷就想跟著一起來,結果被雲瑯給拒絕了。在线av   “大月氏有一個公主叫做梅里亞,美麗異常。av在线视频   像劉陵這樣的健康活潑的漢嫁女子簡直就是鳳毛麟角一般的存在。   單于張開嘴無聲的笑了,指著於單對劉陵道︰“他希望這些漢使活著,好去告訴你的皇帝兄長,大匈奴已經換了王,新的單于就要出現了,今後但凡有禮物,必須送到他手里。”东方在线av   這些天以來,匈奴人不斷地進逼,再不反擊一下,漢軍就會被擠出白登山。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo